To include your compound in the COVID-19 Resource Center, submit it here.

Symic raises $25M in series A-2 round

Symic Biomedical Inc. (San Francisco, Calif.) raised $25 million in a series A-2 round led

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE